634 results on '"Cervantes F."'
Search Results
2. A new mouse of the Peromyscus maniculatus species complex (Cricetidae) from the highlands of central Mexico
3. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
4. A rural environment does not protect against asthma or other allergic diseases amongst Mexican children
5. Novel application of magnetic nano-carbon composite as redox mediator in the reductive biodegradation of iopromide in anaerobic continuous systems
6. Order-fractal transitions in abstract paintings
7. Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
8. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis
9. Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations
10. Driver mutations’ effect in secondary myelofibrosis: an international multicenter study based on 781 patients
11. High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists
12. Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
13. Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia
14. Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results
15. Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
16. Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
17. Concurrence of Anaerobic Ammonium Oxidation and Organotrophic Denitrification in Presence of p-Cresol
18. Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)
19. The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
20. Induction of Tolerance in Renal Transplantation Using Splenic Transplantation: Experimental Study in a Canine Model
21. CALR mutation, MPL mutation and triple negativity identify patients with the lowest vascular risk in primary myelofibrosis
22. Ruxolitinib and survival improvement in patients with myelofibrosis
23. Mutations and prognosis in primary myelofibrosis
24. JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations
25. IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis
26. Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
27. Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders
28. Subtraction of test mass angular noise in the LISA technology package interferometer
29. Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients
30. A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group
31. Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution
32. Mortality due to lung cancer in Mexico
33. Coding sequence and intron–exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients
34. Erratum: Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
35. Quinone-respiration improves dechlorination of carbon tetrachloride by anaerobic sludge
36. Azo dye reduction by thermophilic anaerobic granular sludge, and the impact of the redox mediator anthraquinone-2,6-disulfonate (AQDS) on the reductive biochemical transformation
37. Successful treatment by selective arterial embolization of severe retroperitoneal hemorrhage secondary to bone marrow biopsy in post-polycythemic myelofibrosis
38. The Omiltemi rabbit (Sylvilagus insonus) is not extinct
39. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia
40. Single-agent therapy with oral mercaptopurine for nonlymphoid blast crisis of chronic myeloid leukemia
41. Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status
42. Leukemia risk models in primary myelofibrosis: an International Working Group study
43. Progressive multifocal leukoencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia
44. Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients
45. Inactivating mutations of the histone methyltransferase EZH2 in myeloid disorders: V420
46. Characterization of Photoreceivers for LISA
47. Re: Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients. Alvarez-Larrán A et al
48. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment
49. Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients
50. P53 Tumor suppressor gene in chronic myelogenous leukemia: A sequential study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.